#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoma Familial haemophagocytic lymphohistiocytosis Kawasaki's disease Myocarditis Cutaneous lupus erythematosus Breast angiosarcoma Neuroendocrine carcinoma of the skin Wiskott-Aldrich syndrome Cystic fibrosis respiratory infection suppression Follicular lymphoma stage I Synovial sarcoma Leukoencephalopathy Hodgkin's disease recurrent Autoimmune disorder Epileptic encephalopathy More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Basic Information Rosai-Dorfman syndrome – Trials in Disease Congenital nephrogenic diabetes insipidus – Trials in Disease Mantle cell lymphoma stage IV – Treatment Pulmonary fibrosis – Trials in Disease Sjogren’s syndrome Chondrosarcoma metastatic Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Waldenstrom’s macroglobulinaemia – Basic Information Osteosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efruxifermin Pantothenate Sodium Oditrasertib AZD0516 Nedosiran Gozetotide Alf-18 Erythromycin Cyclophosphamide Monohydrate Baloxavir Marboxil Tipiracil Hydrochloride ACARBOSE Flecainide Acetate Zofenopril Calcium Nms-03305293 Onasemnogene Abeparvovec Brigatinib Istaroxime Perampanel Paracetamol Clobetasol Propionate More therapies…

    Learn about Your Condition

    Atopic keratoconjunctivitis Still's disease T-cell type acute leukaemia Thrombosis Medullary thyroid cancer Mitral valve prolapse Polycystic liver disease Rectal cancer stage III Angiosarcoma Femoral neck fracture Complicated appendicitis Fibrosarcoma metastatic Oropharyngeal cancer Cardiac failure acute Electrocorticogram More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Acetylsalicylic Acid and Cytisine for High-Risk Patients in Preventing Lung Cancer and Reducing Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cytisine
    • Acetylsalicylic Acid
    Italy

  • Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizoaffective disorder
    • Psychotic disorder
    • Schizophrenia
    Investigated Drugs:
    • GT-002
    • Oxazepam
    Denmark

  • Study Comparing Tepotinib to Standard Treatment for Patients with Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tepotinib
    • Atezolizumab
    • Bevacizumab
    France

  • Study on the Effects of Mepolizumab on Nasal Health and Immune Response in Patients with Eosinophilic Granulomatosis with Polyangiitis (eGPA)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Mepolizumab
    The Netherlands

  • Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Dnth103
    Belgium Bulgaria Croatia Denmark France Germany +6

  • Study on the Immune Response and Safety of an RSV Vaccine in Immunocompromised Patients Aged 18 and Older Using Arexvy and Saline

    Recruiting

    2 1 1
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    • Saline
    Austria
Previous Page
1 … 188 189 190 191 192 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!